Targovax (Finland)

Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model

Łukasz Kuryk, Anne‐Sophie W. Møller, Magnus Jäderberg · OncoImmunology · 2018 · 98 citations · Full text

Immunology, Immunoediting, Immunotherapeutics +18

Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies

Mariangela Garofalo, Alessandro Villa, Nicoletta Rizzi et al. · Viruses · 2018 · 88 citations · Full text

Heterologous and cross-species tropism of cancer-derived extracellular vesicles

Mariangela Garofalo, Alessandro Villa, Daniela Crescenti et al. · Theranostics · 2019 · 60 citations · Full text

Synergistic anti‐tumor efficacy of immunogenic adenovirus ONCOS‐102 (Ad5/3‐D24‐GM‐CSF) and standard of care chemotherapy in preclinical mesothelioma model

Łukasz Kuryk, Elina Haavisto, Mariangela Garofalo et al. · International Journal of Cancer · 2016 · 56 citations · Full text

Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma

Łukasz Kuryk, Anne‐Sophie W. Møller, Magnus Jäderberg · Journal of Medical Virology · 2019 · 53 citations · Full text